Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.
about
Management of gastric and duodenal neuroendocrine tumorsEndoscopic diagnosis and management of type I neuroendocrine tumorsThe endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.Gastric carcinoids: between underestimation and overtreatment.Metastatic type 1 gastric carcinoid: a real threat or just a myth?ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms.Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.Review article: the investigation and management of gastric neuroendocrine tumours.Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.Clinical features and management of type I gastric carcinoids.Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.Follow-up of patients with ECL cell-derived tumours.Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors.Somatostatin analogs for gastric carcinoids: For many, but not all.Treatment of type I gastric neuroendocrine tumors with somatostatin analogs.A clinical perspective on gastric neuroendocrine neoplasia.Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate.GASTRIC NEUROENDOCRINE TUMOR: REVIEW AND UPDATE.Development of type I gastric carcinoid in patients with chronic atrophic gastritis.Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
P2860
Q26738541-C5BD35F6-FBF9-4393-B09C-F807B09DFE18Q26824302-00B42B34-84D4-45AE-9D74-BF522FACE508Q34031906-74C3C93F-E14B-43C6-9357-BEF89DAF28BAQ34248487-B60DFA61-56C2-492F-AEE3-A88DAEED3A3DQ35009459-1FE16804-4C84-49C0-91F8-FAE037794BB4Q37192619-84744E98-C4FD-4E48-9ED8-7B3D7C3CDE59Q37408868-CFC498B0-203C-45FE-A007-B356F0798CAAQ37977330-00D31E17-832A-41BC-BCA1-1C2724B47EA1Q38014495-9622BF14-10F3-40CC-9A8E-75A511818305Q38195905-F8623FD9-98A7-4939-ADC3-4C94F49D19BDQ38205916-C9B3D4AF-6491-481F-9E36-41D4465152DCQ38548932-12E30196-23B8-4D1C-A377-0F2EE1064D4DQ38701102-A492C749-426B-4550-B4AF-A67D2974B449Q38755167-D8A79179-1BFF-4FAE-9C39-56ECD01672AFQ38866858-17A4D0CF-4EA7-408B-AEE5-CD95EB5EDA93Q41152322-1787BB4F-42CA-4CFB-8E35-AE7BEB0BDAD5Q42469904-D8209F8D-8A76-47AE-A1E2-C337D9D93FFAQ42533692-B80B9021-E4E8-451A-94EA-F70CAFB5C66CQ43194570-F7F62879-CF82-4F52-BE15-92D832C2D669Q43523129-19C3C1CD-E905-4BE9-A4DC-00C2129EB940Q44309891-FFA118B7-9CE0-4524-A435-690DB3A4AFE8Q47116429-8AE35ACD-0E02-4777-9C54-28D19FDE039AQ51162271-6E35002C-A142-414D-B2A3-CFFB90CBA7CAQ51350256-2EA1665E-65A5-4153-A16A-69522C4C3A47Q51385134-3EBF11D8-F622-49B8-930C-81C2516D3DD2Q51430102-5CE9B683-3774-4F53-A784-B6777AF89B16
P2860
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Long-acting somatostatin analo ...... e 1 gastric carcinoid tumours.
@en
Long-acting somatostatin analo ...... e 1 gastric carcinoid tumours.
@nl
type
label
Long-acting somatostatin analo ...... e 1 gastric carcinoid tumours.
@en
Long-acting somatostatin analo ...... e 1 gastric carcinoid tumours.
@nl
prefLabel
Long-acting somatostatin analo ...... e 1 gastric carcinoid tumours.
@en
Long-acting somatostatin analo ...... e 1 gastric carcinoid tumours.
@nl
P2093
P50
P356
P1476
Long-acting somatostatin analo ...... pe 1 gastric carcinoid tumours
@en
P2093
Chamutal Gur
David J Gross
Dganit Barak
Dimitrios Thomas
Ilan Shimon
Simona Grozinsky-Glasberg
Susana Fichman
P304
P356
10.1530/EJE-08-0420
P577
2008-07-28T00:00:00Z